7 Mar 2024 07:00
Diaceutics PLC
Â
Director / PDMR Shareholding - NED Purchase of Shares
Â
Â
Belfast and London, 07 March 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that on 6 March 2024, Graham Patterson, a Non-Executive Director of Diaceutics, purchased 33,564 ordinary shares at a price of £0.985 per share. As a result of the purchase, Graham Patterson's shareholding in Diaceutics is 33,564 Ordinary Shares representing approximately 0.04% of the Company's issued share capital.
Â
Enquiries:Â
Â
Diaceutics PLC?? | |
Ryan Keeling, Chief Executive Officer  Nick Roberts, Chief Financial Officer  | Tel: +44 (0)28 9040 6500 investorrelations@diaceutics.com |
Stifel Nicolaus Europe Limited (Nomad & Broker)Â | Tel: +44 (0)20 7710 7600Â |
Ben Maddison | |
Nick Harland | |
Kate Hanshaw | |
Alma Strategic Communications | Tel: +44(0)20 3405 0205Â |
Caroline Forde | diaceutics@almastrategic.com |
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
Â
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®
Â
Â
Â
Â
Â
Â
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | |||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||||
a. | Name | Graham Patterson | |||||
2 | Reason for notification |
| |||||
a. | Position/Status | Non-Executive Director | |||||
b. | Initial notification/ Amendment | Initial | |||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a. | Name | Diaceutics PLC | |||||
b. | LEI | 213800VEWQBB39ZB8J81 | |||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary shares of £0.002 each  ISIN: GB00BJQTGV64 | |||||
b. | Nature of the transaction | Purchase | |||||
c. | Price(s) and volume(s) | Share purchase: | |||||
Price(s) | Volume(s) | ||||||
£0.985 | 33,564 | ||||||
d. | Date of the transaction | 6 March 2024 | |||||
e. | Place of the transaction | AIM Market of the London Stock Exchange |
Â
Â